Journal Home
Search for

Volume 91, Issue 2, Pages 644-646 (February 2009)


View previous. 51 of 58 View next.

Premature ovarian failure and dehydroepiandrosterone

Leonidas Mamas, M.D., Ph.D.Corresponding Author Informationemail address, Eudoxia Mamas, B.Sc.

Received 15 October 2007; received in revised form 18 November 2007; accepted 19 November 2007. published online 05 March 2008.

Since the first successful birth at our center following treatment with DHEA in a patient with premature ovarian failure (POF), all subsequent patients with POF underwent the same treatment protocol. Receiving very encouraging results (FSH level was decreased in the first five patients and all achieved pregnancy), it was decided to study the action of DHEA for a reasonable length of time and in a larger number of patients to confirm the effectiveness of this particular therapeutic regime.

Neogenesis IVF Centre, Athens, Greece

Corresponding Author InformationReprint requests: Leonidas Mamas M.D., Ph.D., Neogenesis IVF Centre, 3 Kifisias Ave, 151 23 Marousi, Athens, Greece (FAX: 30-210-6836090).

PII: S0015-0282(07)04120-9

doi:10.1016/j.fertnstert.2007.11.055


View previous. 51 of 58 View next.